Clin2
NCT07004725Possibly a fitNot yet recruiting

Niacin treatment for rheumatoid arthritis with high cholesterol

Rheumatoid Arthritis (RA)

Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.

This study tests whether niacin, a common vitamin, can help reduce inflammation and improve disease activity in people with rheumatoid arthritis who also have high cholesterol. It may offer an additional treatment option without the need for biologics.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be at least 18 years old and weigh at least 35 kg (about 77 lbs).
  • You must have a confirmed diagnosis of rheumatoid arthritis.
  • Your current rheumatoid arthritis medications (like methotrexate or prednisone) must have been at a stable dose for at least 4 weeks.
  • You must have high cholesterol, specifically: total cholesterol between 5.2 and 7.2 mmol/L, or LDL cholesterol between 3.4 and 4.9 mmol/L, or triglycerides between 1.7 and 5.1 mmol/L.
  • You must not be taking any cholesterol-lowering drugs (like statins) or certain heart medications.
  • You must have a body mass index (BMI) between 18.5 and 30.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07800351Not yet recruiting· Phase 3
Nicorandil for heart health in rheumatoid arthritis

This study tests a medicine called nicorandil, which is normally used for chest pain, to see if it can lower the risk of heart disease in people with rheumatoid arthritis. If you have RA and are already on standard treatment, this may help protect your heart.

Tanta, Gharbia Governorate
NCT06753565Recruiting· Phase 2
L-carnitine supplement for rheumatoid arthritis

This trial tests whether adding L-carnitine (a natural substance) to your current treatment helps reduce rheumatoid arthritis symptoms. It could be an option if your arthritis is still active despite taking standard medications.

Cairo, Demerdash
NCT07730723Recruiting· Phase 2/Phase 3
Nicorandil for moderate to severe rheumatoid arthritis

This study tests whether a heart medication called nicorandil can help reduce arthritis symptoms when added to your current treatment. It is for people with moderate to severe rheumatoid arthritis who have been stable on their current treatments.

Cairo, Abbasia
NCT06881966Not yet recruiting
Omega-3 fatty acids for rheumatoid arthritis

This study tests whether taking omega-3 fatty acids (a type of fish oil) can help people with rheumatoid arthritis. If you join, you will receive the supplement or a placebo, and the researchers will see if it reduces your symptoms.

Tunis, Bab Saadoun
NCT07315997Recruiting
Heart health study for people with rheumatoid arthritis

This study looks at whether calcium in the heart arteries and a blood test (troponin) can help predict heart disease risk in people with rheumatoid arthritis. It may help doctors better prevent heart attacks and strokes.

Boston, Massachusetts
NCT07268326Recruiting
Plant-based diet for rheumatoid arthritis

This trial tests whether a plant-based diet can help people with rheumatoid arthritis who have mild disease activity. You must have had RA for at least a year, be on stable medication, and not smoke or take prednisolone.

Frederiksberg

Hear when a new Rheumatoid Arthritis (RA) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.